BioAtla, Inc. (BCAB) Tops Q1 EPS by 13c

BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• BofA Securities on MP Materials (MP): expecting little to no impact from China export control list news
• Johnson Outdoors names Asad Rahman as new CFO effective June 30